View Rule

Printer-Friendly Version Download RIN Data in XML

SSA

RIN: 0960-AG57

Publication ID: Fall 2008

Title: Revised Medical Criteria for Malignant Neoplastic Diseases (3429F)
Abstract: Sections 13.00 and 113.00, Malignant Neoplastic Diseases, of appendix 1 in part 404, subpart P of our regulations describe malignant neoplastic diseases that are considered severe enough to prevent a person from doing any gainful activity, or for a child claiming SSI payments under title XVI, that cause marked and severe functional limitations. We are revising these sections to ensure that the medical evaluation criteria are up-to-date and consistent with the latest advances in medical knowledge and treatment.
Agency: Social Security Administration(SSA)	Priority: Other Significant
RIN Status: Previously published in the Unified Agenda	Agenda Stage of Rulemaking: Final Rule Stage
Major: No	Unfunded Mandates: No
CFR Citation: 20 CFR 404.1500, app 1
Legal Authority: 42 USC 402 42 USC 405(a) 42 USC 405(b) 42 USC 405(d) to 42 USC 405(h) 42 USC 416(i) 42 USC 421(a) 42 USC 421(i) 42 USC 422(c) 42 USC 423 42 USC 425 42 USC 902(a)(5)

Legal Deadline: None

Statement of Need: These final regulations are necessary to update the Malignant Neoplastic Diseases listings to reflect advances in medical knowledge, treatment, and methods of evaluating Malignant Neoplastic Diseases Impairments. They ensure that determinations of disability have a sound medical basis, that claimants receive equal treatment through the use of specific criteria, and that individuals who are disabled can be readily identified and awarded benefits if all other factors of entitlement or eligibility are met.

Summary of the Legal Basis: Administrative--not required by statute or court order.

Alternatives: We considered not revising selected criteria of the listings or making only minor technical changes and continuing to use our current criteria. However, we believe that these revisions are preferable because of the medical advances that have been made in treating and evaluating these types of impairments. The current listings are three years old. It was our intention to monitor these listings and to update the criteria as the need arose. Medical advances in disability evaluation and treatment and our program experience make clear that the current listings do not reflect state-of-the-art medical knowledge and technology.

Anticipated Costs and Benefits: Savings estimates for fiscal years 2009 - 2018: (in millions of dollars) OASDI - 46, SSI - 8.

Risks: None

Timetable:

Action	Date	FR Cite
NPRM	04/28/2008	73 FR 22871
NPRM Comment Period End	06/27/2008
Final Action	04/00/2009

Regulatory Flexibility Analysis Required: No	Government Levels Affected: None
Small Entities Affected: No	Federalism: No
Included in the Regulatory Plan: Yes
Public Comment URL: www.regulations.gov
RIN Data Printed in the FR: No
Agency Contact: Cheryl A. Williams Director Social Security Administration Office of Medical Policy, 6401 Security Boulevard, Baltimore, MD 21235-6401 Phone:410 965-1020 Email: cheryl.a.williams@ssa.gov Rosemarie Greenwald Social Insurance Specialist, Regulations Writer Social Security Administration Office of Regulations, 6401 Security Boulevard, Baltimore, MD 21235-6401 Phone:410 966-7813